The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2021 | Clinical trials for oncogenically driven lung cancer
Samreen Ahmed, FRCP, MD, University Hospitals of Leicester, UK, gives an overview of clinical trials investigating the management of oncogenically driven lung cancer. Prof. Ahmed discusses the need to address questions that will not be explored by pharmaceuticals companies, such as circulating DNA for the detection of disease before clinical manifestation and pulmonary rehabilitation to improve quality of life. This interview took place during the 19th British Thoracic Oncology Group (BTOG) Annual Conference 2021.
